OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Medicine is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis	281
Pathophysiology and mechanism of long COVID: a comprehensive review	244
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines	212
Renal complications in COVID-19: a systematic review and meta-analysis	123
COVID-19: anxiety among hospital staff and associated factors	89
Clinical and inflammatory features based machine learning model for fatal risk prediction of hospitalized COVID-19 patients: results from a retrospective cohort study	88
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry	82
IL-6 and other biomarkers as predictors of severity in COVID-19	75
Demographics, comorbidities and outcomes in hospitalized Covid-19 patients in rural southwest Georgia	71
Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6 – March 29, 2021	67
Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis	65
Unravelling the health effects of fasting: a long road from obesity treatment to healthy life span increase and improved cognition	58
Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019	56
Gut microbes in neurocognitive and mental health disorders	54
Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic	47
The reported effects of the COVID-19 pandemic on people with intellectual disability and their carers: a scoping review	46
Impact of COVID-19 pandemic on routine immunization	44
Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients	42
Handgrip strength is inversely associated with fatal cardiovascular and all-cause mortality events	38
The cardiovascular aspect of COVID-19	37
The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance	37
Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention	36
Influence of gut microbiota on eye diseases: an overview	35
VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy	35
Disparities in case frequency and mortality of coronavirus disease 2019 (COVID-19) among various states in the United States	35

Salivary biomarkers for cancer diagnosis: a meta-analysis	34
Stroke mimics: incidence, aetiology, clinical features and treatment	34
Global, regional and national burden of gastroesophageal reflux disease, 1990–2019: update from the GBD 2019 study	34
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review	33
Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking	33
Estimating the prevalence of overweight and obesity in Nigeria in 2020: a systematic review and meta-analysis	33
The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis	32
Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling	32
Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options	32